Home NDC 63083-4006-2 Hepatitis Nosode
Product NDC 63083-4006
Requested package NDC 63083-4006-2
11-digit product format 630834006
Labeler code 63083
Product ID 63083-4006_613dd686-3d6f-447a-9362-4ecb296b52fb
Type HUMAN OTC DRUG
Nonproprietary name Hepatitis Nosode
Dosage form LIQUID
Route ORAL
Labeler Professional Complementary Health Formulas
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 1984-08-15
Substance HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED); HEPATITIS B VIRUS HBSAG SURFACE PROTEIN ANTIGEN; HEPATITIS C IMMUNE GLOBULIN (HUMAN)
Active strength 30; 30; 30 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL
Pharmacologic classes Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Hepatitis B Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 15 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Hepatitis Nosode
Brand name suffix 4006
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) 30 [hp_X]/59mL HEPATITIS B VIRUS HBSAG SURFACE PROTEIN ANTIGEN 30 [hp_X]/59mL HEPATITIS C IMMUNE GLOBULIN (HUMAN) 30 [hp_X]/59mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 5BFC8LZ6LQ Internal UNII lookup IFJ010MNE4 Internal UNII lookup U5V5MUD1KD Internal UNII lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
FDA-Initiated Inactive NDC Indexing# Effective, Related label table Effective Related label 2026-01-09 N6 2026-01-09 N6 2024-01-30 N6 2024-01-30 N6
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63083-4006-2 Hepatitis Nosode4006 59 mL in 1 BOTTLE, DROPPER LIQUID 59 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63083-4006 HEPATITIS NOSODE 4006 (HEPATITIS NOSODE) LIQUID [PROFESSIONAL COMPLEMENTARY HEALTH FORMULAS] 1 Current NDC, Legacy NDC, 1 package rows 20220226_27fb5026-adb9-4d70-b016-1180e4a46d7f.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 63083-4006-2 63083400602 59 mL in 1 BOTTLE, DROPPER (63083-4006-2) 59 ml 1985-08-15 0000-00-00 No No Current